Search

Your search keyword '"Krance, Robert A"' showing total 777 results

Search Constraints

Start Over You searched for: Author "Krance, Robert A" Remove constraint Author: "Krance, Robert A"
777 results on '"Krance, Robert A"'

Search Results

2. Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival

3. Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma

4. A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

6. Prolonged Cytopenias after Immune Effector Cell Therapy and Lymphodepletion in Patients with Leukemia, Lymphoma, and Solid Tumors

8. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

10. Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

12. Reduced Cumulative Dosing of Alemtuzumab in Patients with Hemophagocytic Lymphohistiocytosis (HLH) Is Associated with Improved Long Term Survival

13. Analyzing the Effects of Obesity and Ethnicity on Outcomes of Pediatric Patients with Hematologic Malignancies Receiving Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide (PTCy): A Single Center Experience

14. Long-Term Follow-up of Outcomes of Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Retrospective Review

15. Long-Term Follow-up of Outcomes of Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia: A Single Center Retrospective Review Spanning More Than 25 Years.

17. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab

21. Outcomes after Hematopoietic Stem Cell Transplantation for Children with I-Cell Disease

22. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.

23. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia

24. Abstract 4 Excellent Event-Free-Survival and Immunoglobulin Independence for Patients with Severe Combined Immunodeficiency Transplanted with Umbilical Cord Blood Stem Cells

25. High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

26. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis

28. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome

29. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

31. Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation

32. Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

33. Supplementary Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

34. Supplementary Tables 1 - 2 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity

35. Supplementary Figure 1 from Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity

36. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

37. Incidence and Outcome of Secondary Graft Failure in Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Single Center Study

38. Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

40. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

41. 2161. Posoleucel, an Allogeneic, Off-the-Shelf Multi-Virus Specific T Cell Therapy, for Severe, Drug-Refractory Viral Infections in Pediatric Patients Following HCT: Results from a Phase 2 Trial

44. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

45. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

46. Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

47. Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia

49. Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

50. Safety and Tolerability of Administering Leukemia-Specific Donor T Cells (mLSTs) after Allogeneic Transplant to Pediatric Patients with AML/MDS

Catalog

Books, media, physical & digital resources